AngioDynamics Expects FY2025 Net Sales Of $282M-$288M Versus Consensus Of $284.367M
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics has projected its fiscal year 2025 net sales to be between $282 million and $288 million, which is in line with the consensus estimate of $284.367 million.
October 03, 2024 | 10:37 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AngioDynamics has announced its FY2025 net sales forecast to be between $282M and $288M, aligning closely with the consensus estimate of $284.367M. This suggests stable revenue expectations.
The sales forecast is in line with market expectations, indicating no significant surprises for investors. This stability suggests a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100